サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1446044

血友病の薬の世界市場に関する洞察、2030年までの予測

Global Medication for Hemophilia Market Insights, Forecast to 2030
出版日: | 発行: QYResearch | ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血友病の薬の世界市場に関する洞察、2030年までの予測
出版日: 2024年03月08日
発行: QYResearch
ページ情報: 英文 115 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、血友病の薬 (Medication for Hemophilia) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の血友病の薬の市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
    • Clotting Factor Replacement Therapy Drugs
    • Non-Factor Therapeutic Drugs
  • 市場：用途別
    • 世界の血友病の薬の市場規模成長率：用途別, 2019 VS 2023 VS 2030
    • Hemophilia A
    • Hemophilia B
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の血友病の薬の市場展望 (2019-2030)
  • 世界の血友病の薬の市場成長トレンド：地域別
    • 血友病の薬 市場規模：地域別: 2019 VS 2023 VS 2030
    • 血友病の薬の市場規模実績：地域別 (2019-2024)
    • 血友病の薬の市場規模予測：地域別 (2025-2030)
  • 血友病の薬 市場動向
    • 血友病の薬 業界動向
    • 血友病の薬 市場の促進要因
    • 血友病の薬 市場の課題
    • 血友病の薬 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 血友病の薬 ：競合別
    • 世界の血友病の薬の収益：企業別 (2019-2024)
    • 世界の血友病の薬の収益シェア：企業別 (2019-2024)
  • 世界の血友病の薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 血友病の薬, 売上高ランキング, 2022 VS 2023 VS 2024
  • 世界の血友病の薬 市場集中度
    • 世界の血友病の薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 血友病の薬の収益 2023
  • 世界の主要企業 血友病の薬 本社 および提供地域
  • 世界の主要企業 血友病の薬, 製品およびアプリケーション
  • 世界の主要企業 血友病の薬, 業界参入時期
  • M&A, 拡張計画

第4章 血友病の薬 内訳データ：タイプ別

  • 世界の血友病の薬の市場規模実績：タイプ別 (2019-2024)
  • 世界の血友病の薬の市場規模予測：タイプ別 (2025-2030)

第5章 血友病の薬 内訳データ：用途別

  • 世界の血友病の薬の市場規模実績：用途別 (2019-2024)
  • 世界の血友病の薬の市場規模予測：用途別 (2025-2030)

第6章 北米

  • 北米の血友病の薬 市場規模 (2019-2030)
  • 北米の血友病の薬 市場規模：タイプ別
    • 北米の血友病の薬 市場規模：タイプ別 (2019-2024)
    • 北米の血友病の薬 市場規模：タイプ別 (2025-2030)
    • 北米の血友病の薬の市場シェア：タイプ別 (2019-2030)
  • 北米の血友病の薬 市場規模：用途別
    • 北米の血友病の薬 市場規模：用途別 (2019-2024)
    • 北米の血友病の薬 市場規模：用途別 (2025-2030)
    • 北米の血友病の薬の市場シェア：用途別 (2019-2030)
  • 北米の血友病の薬 市場規模：国別
    • 北米の血友病の薬 市場規模：国別: 2019 VS 2023 VS 2030
    • 北米の血友病の薬 市場規模：国別 (2019-2024)
    • 北米の血友病の薬 市場規模：国別 (2025-2030)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の血友病の薬 市場規模 (2019-2030)
  • 欧州の血友病の薬 市場規模：タイプ別
    • 欧州の血友病の薬 市場規模：タイプ別 (2019-2024)
    • 欧州の血友病の薬 市場規模：タイプ別 (2025-2030)
    • 欧州の血友病の薬の市場シェア：タイプ別 (2019-2030)
  • 欧州の血友病の薬 市場規模：用途別
    • 欧州の血友病の薬 市場規模：用途別 (2019-2024)
    • 欧州の血友病の薬 市場規模：用途別 (2025-2030)
    • 欧州の血友病の薬の市場シェア：用途別 (2019-2030)
  • 欧州の血友病の薬 市場規模：国別
    • 欧州の血友病の薬 市場規模：国別: 2019 VS 2023 VS 2030
    • 欧州の血友病の薬 市場規模：国別 (2019-2024)
    • 欧州の血友病の薬 市場規模：国別 (2025-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の血友病の薬 市場規模 (2019-2030)
  • 中国の血友病の薬 市場規模：タイプ別
    • 中国の血友病の薬 市場規模：タイプ別 (2019-2024)
    • 中国の血友病の薬 市場規模：タイプ別 (2025-2030)
    • 中国の血友病の薬の市場シェア：タイプ別 (2019-2030)
  • 中国の血友病の薬 市場規模：用途別
    • 中国の血友病の薬 市場規模：用途別 (2019-2024)
    • 中国の血友病の薬 市場規模：用途別 (2025-2030)
    • 中国の血友病の薬の市場シェア：用途別 (2019-2030)

第9章 アジア（中国を除く）

  • アジア地域 血友病の薬 市場規模 (2019-2030)
  • アジア地域 血友病の薬 市場規模：タイプ別
    • アジア地域 血友病の薬 市場規模：タイプ別 (2019-2024)
    • アジア地域 血友病の薬 市場規模：タイプ別 (2025-2030)
    • アジア地域 血友病の薬の市場シェア：タイプ別 (2019-2030)
  • アジア地域 血友病の薬 市場規模：用途別
    • アジア地域 血友病の薬 市場規模：用途別 (2019-2024)
    • アジア地域 血友病の薬 市場規模：用途別 (2025-2030)
    • アジア地域 血友病の薬の市場シェア：用途別 (2019-2030)
  • アジア地域 血友病の薬 市場規模：地域別
    • アジア地域 血友病の薬 市場規模：地域別: 2019 VS 2023 VS 2030
    • アジア地域 血友病の薬 市場規模：地域別 (2019-2024)
    • アジア地域 血友病の薬 市場規模：地域別 (2025-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 血友病の薬 市場規模 (2019-2030)
  • 中近東・アフリカ・中南米 血友病の薬 市場規模：タイプ別
    • 中近東・アフリカ・中南米 血友病の薬 市場規模：タイプ別 (2019-2024)
    • 中近東・アフリカ・中南米 血友病の薬 市場規模：タイプ別 (2025-2030)
    • 中近東・アフリカ・中南米 血友病の薬の市場シェア：タイプ別 (2019-2030)
  • 中近東・アフリカ・中南米 血友病の薬 市場規模：用途別
    • 中近東・アフリカ・中南米 血友病の薬 市場規模：用途別 (2019-2024)
    • 中近東・アフリカ・中南米 血友病の薬 市場規模：用途別 (2025-2030)
    • 中近東・アフリカ・中南米 血友病の薬の市場シェア：用途別 (2019-2030)
  • 中近東・アフリカ・中南米 血友病の薬 市場規模：国別
    • 中近東・アフリカ・中南米 血友病の薬 市場規模：国別: 2019 VS 2023 VS 2030
    • 中近東・アフリカ・中南米 血友病の薬 市場規模：国別 (2019-2024)
    • 中近東・アフリカ・中南米 血友病の薬 市場規模：国別 (2025-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Roche
  • Sanofi
  • BioMarin Pharmaceutical
  • Baxter
  • Pfizer
  • Novo Nordisk
  • Bayer
  • CSL
  • Grifols
  • Octapharma
  • BPL
  • Shire
  • uniQure
  • Genentech
  • CTTQ
  • Hualan Bio

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Medication for Hemophilia Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
  • Table 2. Key Players of Clotting Factor Replacement Therapy Drugs
  • Table 3. Key Players of Non-Factor Therapeutic Drugs
  • Table 4. Global Medication for Hemophilia Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
  • Table 5. Global Medication for Hemophilia Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 6. Global Medication for Hemophilia Market Size by Region (2019-2024) & (US$ Million)
  • Table 7. Global Medication for Hemophilia Market Share by Region (2019-2024)
  • Table 8. Global Medication for Hemophilia Forecasted Market Size by Region (2025-2030) & (US$ Million)
  • Table 9. Global Medication for Hemophilia Market Share by Region (2025-2030)
  • Table 10. Medication for Hemophilia Market Trends
  • Table 11. Medication for Hemophilia Market Drivers
  • Table 12. Medication for Hemophilia Market Challenges
  • Table 13. Medication for Hemophilia Market Restraints
  • Table 14. Global Medication for Hemophilia Revenue by Players (2019-2024) & (US$ Million)
  • Table 15. Global Medication for Hemophilia Revenue Share by Players (2019-2024)
  • Table 16. Global Top Medication for Hemophilia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication for Hemophilia as of 2023)
  • Table 17. Global Medication for Hemophilia Industry Ranking 2022 VS 2023 VS 2024
  • Table 18. Global 5 Largest Players Market Share by Medication for Hemophilia Revenue (CR5 and HHI) & (2019-2024)
  • Table 19. Global Key Players of Medication for Hemophilia, Headquarters and Area Served
  • Table 20. Global Key Players of Medication for Hemophilia, Product and Application
  • Table 21. Global Key Players of Medication for Hemophilia, Product and Application
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
  • Table 24. Global Medication for Hemophilia Revenue Market Share by Type (2019-2024)
  • Table 25. Global Medication for Hemophilia Forecasted Market Size by Type (2025-2030) & (US$ Million)
  • Table 26. Global Medication for Hemophilia Revenue Market Share by Type (2025-2030)
  • Table 27. Global Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
  • Table 28. Global Medication for Hemophilia Revenue Share by Application (2019-2024)
  • Table 29. Global Medication for Hemophilia Forecasted Market Size by Application (2025-2030) & (US$ Million)
  • Table 30. Global Medication for Hemophilia Revenue Share by Application (2025-2030)
  • Table 31. North America Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
  • Table 32. North America Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
  • Table 33. North America Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
  • Table 34. North America Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
  • Table 35. North America Medication for Hemophilia Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 36. North America Medication for Hemophilia Market Size by Country (2019-2024) & (US$ Million)
  • Table 37. North America Medication for Hemophilia Market Size by Country (2025-2030) & (US$ Million)
  • Table 38. Europe Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
  • Table 39. Europe Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
  • Table 40. Europe Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
  • Table 41. Europe Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
  • Table 42. Europe Medication for Hemophilia Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 43. Europe Medication for Hemophilia Market Size by Country (2019-2024) & (US$ Million)
  • Table 44. Europe Medication for Hemophilia Market Size by Country (2025-2030) & (US$ Million)
  • Table 45. China Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
  • Table 46. China Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
  • Table 47. China Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
  • Table 48. China Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
  • Table 49. Asia Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
  • Table 50. Asia Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
  • Table 51. Asia Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
  • Table 52. Asia Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
  • Table 53. Asia Medication for Hemophilia Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 54. Asia Medication for Hemophilia Market Size by Region (2019-2024) & (US$ Million)
  • Table 55. Asia Medication for Hemophilia Market Size by Region (2025-2030) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type (2019-2024) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type (2025-2030) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application (2019-2024) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application (2025-2030) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Medication for Hemophilia Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 61. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country (2019-2024) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country (2025-2030) & (US$ Million)
  • Table 63. Roche Company Details
  • Table 64. Roche Business Overview
  • Table 65. Roche Medication for Hemophilia Product
  • Table 66. Roche Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 67. Roche Recent Developments
  • Table 68. Sanofi Company Details
  • Table 69. Sanofi Business Overview
  • Table 70. Sanofi Medication for Hemophilia Product
  • Table 71. Sanofi Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 72. Sanofi Recent Developments
  • Table 73. BioMarin Pharmaceutical Company Details
  • Table 74. BioMarin Pharmaceutical Business Overview
  • Table 75. BioMarin Pharmaceutical Medication for Hemophilia Product
  • Table 76. BioMarin Pharmaceutical Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 77. BioMarin Pharmaceutical Recent Developments
  • Table 78. Baxter Company Details
  • Table 79. Baxter Business Overview
  • Table 80. Baxter Medication for Hemophilia Product
  • Table 81. Baxter Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 82. Baxter Recent Developments
  • Table 83. Pfizer Company Details
  • Table 84. Pfizer Business Overview
  • Table 85. Pfizer Medication for Hemophilia Product
  • Table 86. Pfizer Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 87. Pfizer Recent Developments
  • Table 88. Novo Nordisk Company Details
  • Table 89. Novo Nordisk Business Overview
  • Table 90. Novo Nordisk Medication for Hemophilia Product
  • Table 91. Novo Nordisk Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 92. Novo Nordisk Recent Developments
  • Table 93. Bayer Company Details
  • Table 94. Bayer Business Overview
  • Table 95. Bayer Medication for Hemophilia Product
  • Table 96. Bayer Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 97. Bayer Recent Developments
  • Table 98. CSL Company Details
  • Table 99. CSL Business Overview
  • Table 100. CSL Medication for Hemophilia Product
  • Table 101. CSL Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 102. CSL Recent Developments
  • Table 103. Grifols Company Details
  • Table 104. Grifols Business Overview
  • Table 105. Grifols Medication for Hemophilia Product
  • Table 106. Grifols Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 107. Grifols Recent Developments
  • Table 108. Octapharma Company Details
  • Table 109. Octapharma Business Overview
  • Table 110. Octapharma Medication for Hemophilia Product
  • Table 111. Octapharma Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 112. Octapharma Recent Developments
  • Table 113. BPL Company Details
  • Table 114. BPL Business Overview
  • Table 115. BPL Medication for Hemophilia Product
  • Table 116. BPL Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 117. BPL Recent Developments
  • Table 118. Shire Company Details
  • Table 119. Shire Business Overview
  • Table 120. Shire Medication for Hemophilia Product
  • Table 121. Shire Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 122. Shire Recent Developments
  • Table 123. uniQure Company Details
  • Table 124. uniQure Business Overview
  • Table 125. uniQure Medication for Hemophilia Product
  • Table 126. uniQure Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 127. uniQure Recent Developments
  • Table 128. Genentech Company Details
  • Table 129. Genentech Business Overview
  • Table 130. Genentech Medication for Hemophilia Product
  • Table 131. Genentech Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 132. Genentech Recent Developments
  • Table 133. CTTQ Company Details
  • Table 134. CTTQ Business Overview
  • Table 135. CTTQ Medication for Hemophilia Product
  • Table 136. CTTQ Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 137. CTTQ Recent Developments
  • Table 138. Hualan Bio Company Details
  • Table 139. Hualan Bio Business Overview
  • Table 140. Hualan Bio Medication for Hemophilia Product
  • Table 141. Hualan Bio Revenue in Medication for Hemophilia Business (2019-2024) & (US$ Million)
  • Table 142. Hualan Bio Recent Developments
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Medication for Hemophilia Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 2. Global Medication for Hemophilia Market Share by Type: 2023 VS 2030
  • Figure 3. Clotting Factor Replacement Therapy Drugs Features
  • Figure 4. Non-Factor Therapeutic Drugs Features
  • Figure 5. Global Medication for Hemophilia Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 6. Global Medication for Hemophilia Market Share by Application: 2023 VS 2030
  • Figure 7. Hemophilia A Case Studies
  • Figure 8. Hemophilia B Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. Medication for Hemophilia Report Years Considered
  • Figure 11. Global Medication for Hemophilia Market Size (US$ Million), Year-over-Year: 2019-2030
  • Figure 12. Global Medication for Hemophilia Market Size, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 13. Global Medication for Hemophilia Market Share by Region: 2023 VS 2030
  • Figure 14. Global Medication for Hemophilia Market Share by Players in 2023
  • Figure 15. Global Top Medication for Hemophilia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication for Hemophilia as of 2023)
  • Figure 16. The Top 10 and 5 Players Market Share by Medication for Hemophilia Revenue in 2023
  • Figure 17. North America Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 18. North America Medication for Hemophilia Market Share by Type (2019-2030)
  • Figure 19. North America Medication for Hemophilia Market Share by Application (2019-2030)
  • Figure 20. North America Medication for Hemophilia Market Share by Country (2019-2030)
  • Figure 21. United States Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 22. Canada Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 23. Europe Medication for Hemophilia Market Size YoY (2019-2030) & (US$ Million)
  • Figure 24. Europe Medication for Hemophilia Market Share by Type (2019-2030)
  • Figure 25. Europe Medication for Hemophilia Market Share by Application (2019-2030)
  • Figure 26. Europe Medication for Hemophilia Market Share by Country (2019-2030)
  • Figure 27. Germany Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 28. France Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 29. U.K. Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 30. Italy Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 31. Russia Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 32. Nordic Countries Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 33. China Medication for Hemophilia Market Size YoY (2019-2030) & (US$ Million)
  • Figure 34. China Medication for Hemophilia Market Share by Type (2019-2030)
  • Figure 35. China Medication for Hemophilia Market Share by Application (2019-2030)
  • Figure 36. Asia Medication for Hemophilia Market Size YoY (2019-2030) & (US$ Million)
  • Figure 37. Asia Medication for Hemophilia Market Share by Type (2019-2030)
  • Figure 38. Asia Medication for Hemophilia Market Share by Application (2019-2030)
  • Figure 39. Asia Medication for Hemophilia Market Share by Region (2019-2030)
  • Figure 40. Japan Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 41. South Korea Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 42. China Taiwan Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 43. Southeast Asia Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 44. India Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 45. Australia Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 46. Middle East, Africa, and Latin America Medication for Hemophilia Market Size YoY (2019-2030) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Type (2019-2030)
  • Figure 48. Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Application (2019-2030)
  • Figure 49. Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Country (2019-2030)
  • Figure 50. Brazil Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 51. Mexico Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 52. Turkey Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 53. Saudi Arabia Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 54. Israel Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 55. GCC Countries Medication for Hemophilia Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 56. Roche Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 57. Sanofi Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 58. BioMarin Pharmaceutical Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 59. Baxter Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 60. Pfizer Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 61. Novo Nordisk Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 62. Bayer Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 63. CSL Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 64. Grifols Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 65. Octapharma Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 66. BPL Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 67. Shire Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 68. uniQure Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 69. Genentech Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 70. CTTQ Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 71. Hualan Bio Revenue Growth Rate in Medication for Hemophilia Business (2019-2024)
  • Figure 72. Bottom-up and Top-down Approaches for This Report
  • Figure 73. Data Triangulation
  • Figure 74. Key Executives Interviewed
目次

This research report focuses on the Medication for Hemophilia Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Medication for Hemophilia Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Clotting Factor Replacement Therapy Drugs
    • 1.2.3 Non-Factor Therapeutic Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Medication for Hemophilia Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Hemophilia A
    • 1.3.3 Hemophilia B
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Medication for Hemophilia Market Perspective (2019-2030)
  • 2.2 Global Medication for Hemophilia Growth Trends by Region
    • 2.2.1 Medication for Hemophilia Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Medication for Hemophilia Historic Market Size by Region (2019-2024)
    • 2.2.3 Medication for Hemophilia Forecasted Market Size by Region (2025-2030)
  • 2.3 Medication for Hemophilia Market Dynamics
    • 2.3.1 Medication for Hemophilia Industry Trends
    • 2.3.2 Medication for Hemophilia Market Drivers
    • 2.3.3 Medication for Hemophilia Market Challenges
    • 2.3.4 Medication for Hemophilia Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Medication for Hemophilia by Players
    • 3.1.1 Global Medication for Hemophilia Revenue by Players (2019-2024)
    • 3.1.2 Global Medication for Hemophilia Revenue Market Share by Players (2019-2024)
  • 3.2 Global Medication for Hemophilia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Medication for Hemophilia, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Medication for Hemophilia Market Concentration Ratio
    • 3.4.1 Global Medication for Hemophilia Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Medication for Hemophilia Revenue in 2023
  • 3.5 Global Key Players of Medication for Hemophilia Head office and Area Served
  • 3.6 Global Key Players of Medication for Hemophilia, Product and Application
  • 3.7 Global Key Players of Medication for Hemophilia, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Medication for Hemophilia Breakdown Data by Type

  • 4.1 Global Medication for Hemophilia Historic Market Size by Type (2019-2024)
  • 4.2 Global Medication for Hemophilia Forecasted Market Size by Type (2025-2030)

5 Medication for Hemophilia Breakdown Data by Application

  • 5.1 Global Medication for Hemophilia Historic Market Size by Application (2019-2024)
  • 5.2 Global Medication for Hemophilia Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Medication for Hemophilia Market Size (2019-2030)
  • 6.2 North America Medication for Hemophilia Market Size by Type
    • 6.2.1 North America Medication for Hemophilia Market Size by Type (2019-2024)
    • 6.2.2 North America Medication for Hemophilia Market Size by Type (2025-2030)
    • 6.2.3 North America Medication for Hemophilia Market Share by Type (2019-2030)
  • 6.3 North America Medication for Hemophilia Market Size by Application
    • 6.3.1 North America Medication for Hemophilia Market Size by Application (2019-2024)
    • 6.3.2 North America Medication for Hemophilia Market Size by Application (2025-2030)
    • 6.3.3 North America Medication for Hemophilia Market Share by Application (2019-2030)
  • 6.4 North America Medication for Hemophilia Market Size by Country
    • 6.4.1 North America Medication for Hemophilia Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Medication for Hemophilia Market Size by Country (2019-2024)
    • 6.4.3 North America Medication for Hemophilia Market Size by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Medication for Hemophilia Market Size (2019-2030)
  • 7.2 Europe Medication for Hemophilia Market Size by Type
    • 7.2.1 Europe Medication for Hemophilia Market Size by Type (2019-2024)
    • 7.2.2 Europe Medication for Hemophilia Market Size by Type (2025-2030)
    • 7.2.3 Europe Medication for Hemophilia Market Share by Type (2019-2030)
  • 7.3 Europe Medication for Hemophilia Market Size by Application
    • 7.3.1 Europe Medication for Hemophilia Market Size by Application (2019-2024)
    • 7.3.2 Europe Medication for Hemophilia Market Size by Application (2025-2030)
    • 7.3.3 Europe Medication for Hemophilia Market Share by Application (2019-2030)
  • 7.4 Europe Medication for Hemophilia Market Size by Country
    • 7.4.1 Europe Medication for Hemophilia Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Medication for Hemophilia Market Size by Country (2019-2024)
    • 7.4.3 Europe Medication for Hemophilia Market Size by Country (2025-2030)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Medication for Hemophilia Market Size (2019-2030)
  • 8.2 China Medication for Hemophilia Market Size by Type
    • 8.2.1 China Medication for Hemophilia Market Size by Type (2019-2024)
    • 8.2.2 China Medication for Hemophilia Market Size by Type (2025-2030)
    • 8.2.3 China Medication for Hemophilia Market Share by Type (2019-2030)
  • 8.3 China Medication for Hemophilia Market Size by Application
    • 8.3.1 China Medication for Hemophilia Market Size by Application (2019-2024)
    • 8.3.2 China Medication for Hemophilia Market Size by Application (2025-2030)
    • 8.3.3 China Medication for Hemophilia Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Medication for Hemophilia Market Size (2019-2030)
  • 9.2 Asia Medication for Hemophilia Market Size by Type
    • 9.2.1 Asia Medication for Hemophilia Market Size by Type (2019-2024)
    • 9.2.2 Asia Medication for Hemophilia Market Size by Type (2025-2030)
    • 9.2.3 Asia Medication for Hemophilia Market Share by Type (2019-2030)
  • 9.3 Asia Medication for Hemophilia Market Size by Application
    • 9.3.1 Asia Medication for Hemophilia Market Size by Application (2019-2024)
    • 9.3.2 Asia Medication for Hemophilia Market Size by Application (2025-2030)
    • 9.3.3 Asia Medication for Hemophilia Market Share by Application (2019-2030)
  • 9.4 Asia Medication for Hemophilia Market Size by Region
    • 9.4.1 Asia Medication for Hemophilia Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Medication for Hemophilia Market Size by Region (2019-2024)
    • 9.4.3 Asia Medication for Hemophilia Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Medication for Hemophilia Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Medication for Hemophilia Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Medication for Hemophilia Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Medication for Hemophilia Introduction
    • 11.1.4 Roche Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.1.5 Roche Recent Developments
  • 11.2 Sanofi
    • 11.2.1 Sanofi Company Details
    • 11.2.2 Sanofi Business Overview
    • 11.2.3 Sanofi Medication for Hemophilia Introduction
    • 11.2.4 Sanofi Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.2.5 Sanofi Recent Developments
  • 11.3 BioMarin Pharmaceutical
    • 11.3.1 BioMarin Pharmaceutical Company Details
    • 11.3.2 BioMarin Pharmaceutical Business Overview
    • 11.3.3 BioMarin Pharmaceutical Medication for Hemophilia Introduction
    • 11.3.4 BioMarin Pharmaceutical Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.3.5 BioMarin Pharmaceutical Recent Developments
  • 11.4 Baxter
    • 11.4.1 Baxter Company Details
    • 11.4.2 Baxter Business Overview
    • 11.4.3 Baxter Medication for Hemophilia Introduction
    • 11.4.4 Baxter Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.4.5 Baxter Recent Developments
  • 11.5 Pfizer
    • 11.5.1 Pfizer Company Details
    • 11.5.2 Pfizer Business Overview
    • 11.5.3 Pfizer Medication for Hemophilia Introduction
    • 11.5.4 Pfizer Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.5.5 Pfizer Recent Developments
  • 11.6 Novo Nordisk
    • 11.6.1 Novo Nordisk Company Details
    • 11.6.2 Novo Nordisk Business Overview
    • 11.6.3 Novo Nordisk Medication for Hemophilia Introduction
    • 11.6.4 Novo Nordisk Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.6.5 Novo Nordisk Recent Developments
  • 11.7 Bayer
    • 11.7.1 Bayer Company Details
    • 11.7.2 Bayer Business Overview
    • 11.7.3 Bayer Medication for Hemophilia Introduction
    • 11.7.4 Bayer Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.7.5 Bayer Recent Developments
  • 11.8 CSL
    • 11.8.1 CSL Company Details
    • 11.8.2 CSL Business Overview
    • 11.8.3 CSL Medication for Hemophilia Introduction
    • 11.8.4 CSL Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.8.5 CSL Recent Developments
  • 11.9 Grifols
    • 11.9.1 Grifols Company Details
    • 11.9.2 Grifols Business Overview
    • 11.9.3 Grifols Medication for Hemophilia Introduction
    • 11.9.4 Grifols Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.9.5 Grifols Recent Developments
  • 11.10 Octapharma
    • 11.10.1 Octapharma Company Details
    • 11.10.2 Octapharma Business Overview
    • 11.10.3 Octapharma Medication for Hemophilia Introduction
    • 11.10.4 Octapharma Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.10.5 Octapharma Recent Developments
  • 11.11 BPL
    • 11.11.1 BPL Company Details
    • 11.11.2 BPL Business Overview
    • 11.11.3 BPL Medication for Hemophilia Introduction
    • 11.11.4 BPL Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.11.5 BPL Recent Developments
  • 11.12 Shire
    • 11.12.1 Shire Company Details
    • 11.12.2 Shire Business Overview
    • 11.12.3 Shire Medication for Hemophilia Introduction
    • 11.12.4 Shire Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.12.5 Shire Recent Developments
  • 11.13 uniQure
    • 11.13.1 uniQure Company Details
    • 11.13.2 uniQure Business Overview
    • 11.13.3 uniQure Medication for Hemophilia Introduction
    • 11.13.4 uniQure Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.13.5 uniQure Recent Developments
  • 11.14 Genentech
    • 11.14.1 Genentech Company Details
    • 11.14.2 Genentech Business Overview
    • 11.14.3 Genentech Medication for Hemophilia Introduction
    • 11.14.4 Genentech Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.14.5 Genentech Recent Developments
  • 11.15 CTTQ
    • 11.15.1 CTTQ Company Details
    • 11.15.2 CTTQ Business Overview
    • 11.15.3 CTTQ Medication for Hemophilia Introduction
    • 11.15.4 CTTQ Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.15.5 CTTQ Recent Developments
  • 11.16 Hualan Bio
    • 11.16.1 Hualan Bio Company Details
    • 11.16.2 Hualan Bio Business Overview
    • 11.16.3 Hualan Bio Medication for Hemophilia Introduction
    • 11.16.4 Hualan Bio Revenue in Medication for Hemophilia Business (2019-2024)
    • 11.16.5 Hualan Bio Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details